REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 166 filers reported holding REGENXBIO INC in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,320,344 | -18.7% | 201,722 | -1.3% | 0.00% | 0.0% |
| Q2 2023 | $4,084,817 | +29935.4% | 204,343 | -71.6% | 0.00% | -75.0% |
| Q1 2023 | $13,600 | +2647.5% | 719,211 | +3194.3% | 0.01% | – |
| Q4 2022 | $495 | -99.9% | 21,832 | +28.1% | 0.00% | – |
| Q3 2022 | $450,000 | -93.8% | 17,043 | -92.2% | 0.00% | -100.0% |
| Q1 2022 | $7,246,000 | +674.1% | 218,316 | +663.0% | 0.00% | – |
| Q4 2021 | $936,000 | +261.4% | 28,613 | +363.6% | 0.00% | – |
| Q3 2021 | $259,000 | -96.6% | 6,172 | -96.8% | 0.00% | -100.0% |
| Q2 2021 | $7,581,000 | +4.6% | 195,127 | -8.1% | 0.01% | 0.0% |
| Q1 2021 | $7,246,000 | +438.3% | 212,421 | +615.6% | 0.01% | – |
| Q4 2020 | $1,346,000 | +250.5% | 29,686 | +112.5% | 0.00% | – |
| Q3 2020 | $384,000 | -93.2% | 13,970 | -90.9% | 0.00% | -100.0% |
| Q2 2020 | $5,684,000 | +31.5% | 154,344 | +46.3% | 0.01% | +60.0% |
| Q4 2019 | $4,322,000 | +140.4% | 105,496 | +201.4% | 0.01% | +66.7% |
| Q2 2019 | $1,798,000 | -37.3% | 35,000 | -30.0% | 0.00% | -25.0% |
| Q1 2019 | $2,866,000 | -70.9% | 50,000 | -61.6% | 0.00% | -66.7% |
| Q3 2018 | $9,833,000 | +279.7% | 130,238 | +260.8% | 0.01% | +300.0% |
| Q2 2018 | $2,590,000 | -62.4% | 36,102 | -84.4% | 0.00% | -66.7% |
| Q1 2018 | $6,890,000 | -30.1% | 230,837 | -22.1% | 0.01% | -30.8% |
| Q4 2017 | $9,854,000 | +927.5% | 296,358 | +918.4% | 0.01% | +1200.0% |
| Q3 2017 | $959,000 | -84.8% | 29,100 | -90.9% | 0.00% | -90.9% |
| Q2 2017 | $6,325,000 | -55.8% | 320,247 | -56.9% | 0.01% | -57.7% |
| Q1 2017 | $14,325,000 | +67.8% | 742,237 | +61.3% | 0.03% | +44.4% |
| Q4 2016 | $8,535,000 | +28.6% | 460,114 | -2.9% | 0.02% | +63.6% |
| Q3 2016 | $6,639,000 | +1222.5% | 473,852 | +654.6% | 0.01% | +1000.0% |
| Q2 2016 | $502,000 | +193.6% | 62,793 | +296.6% | 0.00% | – |
| Q1 2016 | $171,000 | -86.6% | 15,832 | -79.5% | 0.00% | -100.0% |
| Q4 2015 | $1,279,000 | +3.1% | 77,075 | +36.9% | 0.00% | +50.0% |
| Q3 2015 | $1,240,000 | – | 56,303 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |